Getting pharmaceutical R&D back on target
- 17 May 2011
- journal article
- Published by Springer Science and Business Media LLC in Nature Chemical Biology
- Vol. 7 (6), 335-339
- https://doi.org/10.1038/nchembio.581
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Too many roads not takenNature, 2011
- Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targetsNature Reviews Drug Discovery, 2010
- Suppression of inflammation by a synthetic histone mimicNature, 2010
- Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?Cell, 2010
- Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactorBioorganic & Medicinal Chemistry, 2010
- Small‐molecule protein–protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerationsIUBMB Life, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- Spending on new drug development1Health Economics, 2009
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- The druggable genomeNature Reviews Drug Discovery, 2002